Results 31 to 40 of about 8,677 (217)

Functional reprogramming of peripheral blood monocytes by soluble mediators in patients with pancreatic cancer and intraductal papillary mucinous neoplasms

Frontiers in Immunology, 2023
BackgroundMonocytes and monocyte-derived tumor infiltrating cells have been implicated in the immunosuppression and immune evasion associated with pancreatic adenocarcinoma (PDAC).
Austin M. Eckhoff, Michael C. Brown, Karenia Landa, Ibtehaj Naqvi, Eda K. Holl, David Boczkowski, Ashley Fletcher, Kristen E. Rhodin, Minh Huy Giang, Bruce Sullenger, Georgia M. Beasley, Peter J. Allen, Smita K. Nair, Smita K. Nair, Smita K. Nair   +14 more
doaj   +1 more source

Controversies in the management of pancreatic IPMN [PDF]

Nature Reviews Gastroenterology & Hepatology, 2011
Although considerable progress has been made in our understanding of intraductal papillary mucinous neoplasm (IPMN) of the pancreas, some issues still remain to be resolved. Uncertainty exists regarding the classification of IPMNs. The necessity of the mixed-type category of IPMN and whether such lesions should be defined radiographically or ...
openaire   +3 more sources

Total duodeno-pancreatectomy for intraductal papillary and mucinous tumor of the pancreas: report of a complex case.

Batna Journal of Medical Sciences
Intraductal papillary mucinous neoplasms of the pancreas (IPMNs) are rare cystic neoplasms with significant malignant potential. Treatment is primarily based on surgical resection, tailored to the patient’s radiological and clinical profile.
Youcef KHENCHOUL, Hichem El Azhari BENMAMAR, Mustapha BOUMENDJEL, Dalel ZERROUK, Imen HAMIOUDA   +4 more
doaj   +1 more source

The efficacy of pancreatic juice cytology with liquid-based cytology for evaluating malignancy in patients with intraductal papillary mucinous neoplasm

BMC Gastroenterology, 2020
Background Pancreatic juice cytology (PJC) is a tool for diagnosing malignant intraductal papillary mucinous neoplasm (IPMN); however, the accuracy is insufficient using the conventional method. Liquid-based cytology (LBC) improves the cell recovery rate,
Kazuya Miyamoto, Kazuyuki Matsumoto, Hironari Kato, Ryuichi Yoshida, Yuzo Umeda, Hirohumi Inoue, Takehiro Tanaka, Akihiro Matsumi, Yosuke Saragai, Yuki Fujii, Tatsuhiro Yamazaki, Daisuke Uchida, Takeshi Tomoda, Shigeru Horiguchi, Takahito Yagi, Hiroyuki Okada   +15 more
doaj   +1 more source

Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression

Frontiers in Oncology, 2023
IntroductionPancreatic ductal adenocarcinoma (PDAC) is lethal due to its late diagnosis and lack of successful treatments. A possible strategy to reduce its death burden is prevention.
Manuel Gentiluomo, Chiara Corradi, Paolo Giorgio Arcidiacono, Stefano Crippa, Massimo Falconi, Giulio Belfiori, Riccardo Farinella, Laura Apadula, Gaetano Lauri, Niccolò Bina, Cosmeri Rizzato, Federico Canzian, Luca Morelli, Gabriele Capurso, Gabriele Capurso, Daniele Campa   +15 more
doaj   +1 more source

Schema of pancreatic ductal adenocarcinoma (PDAC) with associated intraductal papillary mucinous neoplasm (IPMN).

, 2014
A. The KRAS mutation was detected in ordinary PDAC without IPMN. B. KRAS and GNAS mutations were detected in IPMN. C. KRAS and GNAS mutations were detected in PDAC derived from primary IPMN. D.
Mika Miura (205029), Tadashi Sato (572698), Shinya Maekawa (205015), Mitsuharu Fukasawa (572696), Makoto Kadokura (205009), Ei Takahashi (572697), Hiroko Shindo (205040), Nobuyuki Enomoto (92837), Shinichi Takano (572695)   +8 more
core   +1 more source

Intraductal papillary mucinous neoplasm (IPMN):UPDATE [PDF]

論文(Article)At present, IPMN is broadly divided into two main types: main duct and branch duct. However, as discussed below, the definition of mixed-type IPMN is gradually becoming accepted.
木村, 理
core   +1 more source

Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas: an Update in Definition, Time to Progression, and Surgical Management

, 2022
Aim of our update is to present the “state of art” about pancreatic intraductal papillary mucinous neoplasms (IPMN) and underline some significant notions that can be helpful in clinical practice.
Carlei F., Giuliani A., Lazzarin G., Schietroma M., Romano L.   +4 more
core   +1 more source

Image Quality of 1.5 T MRI Using Dual‐Type Deep Learning Reconstruction for Pancreatic Cystic Lesions: An Exploratory Comparison With Conventional 3 T MRI Without Deep Learning Reconstruction

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Dual‐type deep learning reconstruction (DLR) may improve the pancreatic MRI image quality; however, the effects of different DLR strengths at 1.5 T compared with the conventional 1.5 T and 3 T MRI without DLR remain unclear. Purpose To evaluate the image quality of 1.5 T MRI reconstructed with different DLR strengths for pancreatic ...
Masaki Tsuda, Taiki Nozaki, Koji Sumi, Minobu Kamo, Ippei Ozaki, Fumio Morimura, Eugene Nishi, Yohsuke Suyama, Hiroaki Sugiura, Hiromi Edo   +9 more
wiley   +1 more source

An Assessment of IPMN Screening in Liver Transplant Recipients

, 2023
Introduction: Management of intraductal papillary mucinous neoplasm (IPMN) is controversial, and several guidelines have aimed to establish an adequate strategy for surveillance.
Rehman, Sheema, Ali, Suhaib A, Jafri, Syed-Mohammed, Samad, Momin, Chaudhary, Ammad   +4 more
core   +1 more source